Skip to content
PubMed This is a summary of 19 peer-reviewed journal articles Updated
Neuro-ophthalmology

When Medicine Isn't Enough: Surgical Options for IIH

At a Glance

Surgery for IIH is reserved for cases where vision worsens despite maximum medication or during rapid vision loss emergencies. Main options include Venous Sinus Stenting (VSS) to improve drainage, Optic Nerve Sheath Fenestration (ONSF) to protect sight, and CSF shunts to lower brain pressure.

Surgery for Idiopathic Intracranial Hypertension (IIH) is generally not the first step. It is reserved for specific situations where medications aren’t enough to protect your health [1][2]. Most doctors recommend surgery in two main scenarios:

  1. Refractory IIH: When your vision continues to get worse despite taking the maximum dose of medications like acetazolamide [2][1].
  2. Fulminant IIH: A rare, emergency situation where vision is lost very rapidly—sometimes over just a few days—requiring immediate “salvage” surgery [3][4].

Surgical Options Comparison

There are three main types of surgery for IIH. They work in very different ways and have different goals.

Procedure Primary Goal How it Works Pros Cons
Venous Sinus Stenting (VSS) Lowers overall pressure [5] A mesh tube (stent) is placed in a narrowed vein to improve drainage [6] Addresses the “plumbing” issue; lower revision rate than shunts [7] Requires blood thinners after surgery; only works if you have narrowing (stenosis) [8]
Optic Nerve Sheath Fenestration (ONSF) Protects vision only [9] Small slits are made in the coating of the optic nerve to drain fluid [10] Excellent for urgent vision salvage; very safe for the brain [11] Often does not fix headaches; fluid can still be high in the rest of the brain [12]
CSF Shunting (VP or LP Shunt) Lowers overall pressure [13] A tube is placed to drain fluid from the brain/spine into the abdomen [2] Effective for both vision and headaches [12] High rate of “failure” or blockage, often requiring multiple “revision” surgeries [2][14]

Venous Sinus Stenting (VSS)

VSS is an “endovascular” procedure, meaning it is done through the blood vessels rather than by opening the skull [5]. It is only an option if your imaging (MRV or CTV) shows transverse sinus stenosis—a significant narrowing of the veins that drain fluid from your brain [6][8]. By propping these veins open, the fluid can drain more naturally, which often resolves the pressure, the “whooshing” sound in the ears, and the headaches [15][16].

Optic Nerve Sheath Fenestration (ONSF)

Think of ONSF as a “pressure release valve” specifically for your eyes. Because it only drains the fluid sitting right behind the eye, it is one of the best ways to stop papilledema (optic nerve swelling) and save your sight [9][10]. However, because it doesn’t lower the pressure in the rest of the brain, most patients find that their headaches do not improve after this surgery [17][18].

Cerebrospinal Fluid (CSF) Shunting

A Ventriculoperitoneal (VP) or Lumboperitoneal (LP) shunt is a tube that diverts excess fluid to your abdomen, where it is harmlessly absorbed [2]. While shunts are very effective at lowering pressure throughout the entire system, they are notorious for getting blocked, moving out of place, or becoming infected [2]. Many patients who receive a shunt will eventually need at least one “revision” surgery to fix a malfunction [14][19].

Choosing the Right Path

Your care team—usually involving a neuro-ophthalmologist and a neurosurgeon—will help you weigh these options. The choice often depends on whether your biggest threat is permanent vision loss or unmanageable headache pain, and what your specific “brain plumbing” looks like on your scans [2][1].

Common questions in this guide

Am I a candidate for venous sinus stenting (VSS)?
VSS is an option only if your imaging shows transverse sinus stenosis, which is a narrowing of the veins that drain fluid from your brain. Your doctor will measure the pressure in your brain's veins to determine if this procedure will effectively relieve your symptoms.
Will optic nerve sheath fenestration (ONSF) cure my headaches?
ONSF acts as a pressure release valve specifically for your eyes to protect your vision. Because it does not lower the overall fluid pressure in the rest of your brain, most patients find that their headaches do not significantly improve after this surgery.
What are the risks of getting a CSF shunt for IIH?
While VP or LP shunts effectively lower overall brain pressure and relieve headaches, they have a high rate of malfunction. Shunts can become blocked, move out of place, or get infected, which often requires additional revision surgeries to fix the tubing.
What does it mean to have fulminant IIH?
Fulminant IIH is a rare medical emergency where vision loss happens very rapidly, sometimes over just a few days. In these urgent situations, doctors typically prioritize immediate salvage surgeries like ONSF to protect your sight before permanent damage occurs.
Will I need to take blood thinners after IIH surgery?
If you undergo venous sinus stenting (VSS), you will generally need to take blood thinners after the procedure. This medication helps keep the newly placed mesh tube open and prevents dangerous blood clots from forming in the treated vein.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Am I a candidate for venous sinus stenting (VSS), and what was the pressure gradient measured in my brain's veins?
  2. 2.If we choose optic nerve sheath fenestration (ONSF), what is our plan for managing my headaches, since that procedure only targets vision?
  3. 3.Given the high revision rates for VP/LP shunts, how do you handle shunt malfunctions or blockages in your practice?
  4. 4.Is my vision loss 'fulminant' (rapidly progressing), and does that change which surgery we should prioritize?
  5. 5.Will I need to be on long-term blood thinners if I receive a stent?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (19)
  1. 1

    Current Indications for Management Options in Pseudotumor Cerebri.

    Akhter A, Schulz L, Inger HE, McGregor JM

    Neurologic clinics 2022; (40(2)):391-404 doi:10.1016/j.ncl.2021.11.011.

    PMID: 35465882
  2. 2

    Outcomes of endoscopic optic nerve decompression in patients with idiopathic intracranial hypertension.

    Tarrats L, Hernández G, Busquets JM, et al.

    International forum of allergy & rhinology 2017; (7(6)):615-623 doi:10.1002/alr.21927.

    PMID: 28383199
  3. 3

    Fulminant Idiopathic Intracranial Hypertension.

    Bouffard MA

    Current neurology and neuroscience reports 2020; (20(4)):8 doi:10.1007/s11910-020-1026-8.

    PMID: 32219578
  4. 4

    Fulminant idiopathic intracranial hypertension mimicking Chiari I malformation in a pediatric patient: diagnostic value of MRI and promising outcomes with venous sinus stenting.

    Krouma M, Kerleroux B, Desnous B, et al.

    Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 2025; (41(1)):284 doi:10.1007/s00381-025-06907-0.

    PMID: 40970992
  5. 5

    Outcomes of Stenting in Atypical Idiopathic Intracranial Hypertension Patients With Transverse Sinus Stenosis.

    Song S, Guan Z, Wang S, et al.

    Brain and behavior 2025; (15(2)):e70351 doi:10.1002/brb3.70351.

    PMID: 39972974
  6. 6

    Recommendations for the selection and treatment of patients with idiopathic intracranial hypertension for venous sinus stenting.

    Fargen KM, Liu K, Garner RM, et al.

    Journal of neurointerventional surgery 2018; (10(12)):1203-1208 doi:10.1136/neurintsurg-2018-014042.

    PMID: 30030306
  7. 7

    Intracranial venous stenting for idiopathic intracranial hypertension.

    Ong F, Phillips T, Selkirk G, McAuliffe W

    Journal of medical imaging and radiation oncology 2023; (67(5)):526-530 doi:10.1111/1754-9485.13505.

    PMID: 36645196
  8. 8

    Dynamic intraoperative changes in intracranial pressure during venous stenting.

    Sollenberger CH, Wu AQ, Scott KW, et al.

    Journal of neurointerventional surgery 2025; (17(8)):793 doi:10.1136/jnis-2025-023464.

    PMID: 40659482
  9. 9

    Visual recovery after unilateral optic nerve sheath fenestration for pseudotumor cerebri syndrome.

    Dai YL, Ramsey DJ, Athappilly GK, Tucker SM

    Orbit (Amsterdam, Netherlands) 2023; (42(4)):397-403 doi:10.1080/01676830.2022.2118791.

    PMID: 36069075
  10. 10

    Optic Nerve Sheath Fenestration: A Retrospective Review of Its Safety, Efficacy, and Impact on Optical Coherence Tomography.

    Gupta L, Vora P, Benningfield M, et al.

    Ophthalmic plastic and reconstructive surgery 2025; (41(2)):213-220 doi:10.1097/IOP.0000000000002792.

    PMID: 39378203
  11. 11

    Efficacy of Optic Nerve Sheath Fenestration in Patients with Increased Intracranial Pressure.

    Özcan SC, Deveci N, Özarslan Özcan D, Önder F

    Turkish journal of ophthalmology 2023; (53(1)):13-17 doi:10.4274/tjo.galenos.2022.45057.

    PMID: 36847628
  12. 12

    Time to re-assess the treatment of idiopathic intracranial hypertension.

    Albuquerque FC, Gross BA, Levitt MR

    Journal of neurointerventional surgery 2016; (8(6)):549-50 doi:10.1136/neurintsurg-2016-012460.

    PMID: 27178402
  13. 13

    [Indications and technique for transconjunctival optic nerve sheath fenestration : Video article].

    Lagrèze WA, Gross N, Biermann J, Joachimsen L

    Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 2017; (114(10)):953-958 doi:10.1007/s00347-017-0563-2.

    PMID: 28905110
  14. 14

    Venous sinus stenting in idiopathic intracranial hypertension: a safer surgical approach?

    Chaudhry S, Bryant TK, Peeler CE

    Current opinion in ophthalmology 2016; (27(6)):481-485 doi:10.1097/ICU.0000000000000315.

    PMID: 27585210
  15. 15

    Transverse venous sinus stenting for idiopathic intracranial hypertension: Safety and feasibility.

    Koovor JM, Lopez GV, Riley K, Tejada J

    The neuroradiology journal 2018; (31(5)):513-517 doi:10.1177/1971400918782320.

    PMID: 29882475
  16. 16

    Idiopathic Intracranial Venous Hypertension: Toward a Better Understanding of Venous Stenosis and the Role of Stenting in Idiopathic Intracranial Hypertension.

    Dinkin MJ, Patsalides A

    Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society 2023; (43(4)):451-463 doi:10.1097/WNO.0000000000001898.

    PMID: 37410913
  17. 17

    Does optic nerve sheath fenestration alleviate headaches in patients with idiopathic intracranial hypertension? A retrospective study.

    Özdemir HN, Çelebisoy N, Gökçay F, et al.

    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2025; (139()):111447 doi:10.1016/j.jocn.2025.111447.

    PMID: 40602272
  18. 18

    Surgical Interventions in Idiopathic Intracranial Hypertension-A Comprehensive Multi-Center Study of Outcome and the Role of Treatment Indication.

    Bsteh G, Hansen NS, Zaic S, et al.

    European journal of neurology 2026; (33(3)):e70541 doi:10.1111/ene.70541.

    PMID: 41782183
  19. 19

    Mastoiditis caused by intracranial venous sinus stenting in an idiopathic intracranial hypertension patient.

    Tian L

    Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences 2019; (25(4)):478-480 doi:10.1177/1591019918824864.

    PMID: 31190591

This page is for informational purposes only and does not replace professional medical advice. Always consult your neuro-ophthalmologist or neurosurgeon to determine which surgical or medical treatment is right for your specific condition.

Get notified when new evidence is published on Idiopathic intracranial hypertension.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.